• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma.

作者信息

Cogen Anna L, Parekh Vishwas, Gangadhar Tara, Lipoff Jules B

机构信息

Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.

Department of Pathology, City of Hope National Medical Center, Duarte, California.

出版信息

JAAD Case Rep. 2018 Jan 16;4(2):132-134. doi: 10.1016/j.jdcr.2017.12.002. eCollection 2018 Mar.

DOI:10.1016/j.jdcr.2017.12.002
PMID:29387763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5789761/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1242/5789761/a7d3cb99bb76/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1242/5789761/599da0281977/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1242/5789761/a7d3cb99bb76/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1242/5789761/599da0281977/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1242/5789761/a7d3cb99bb76/gr2.jpg

相似文献

1
Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma.一名转移性黑色素瘤患者中与帕博利珠单抗相关的扁平苔藓样毛发角化病。
JAAD Case Rep. 2018 Jan 16;4(2):132-134. doi: 10.1016/j.jdcr.2017.12.002. eCollection 2018 Mar.
2
Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanoma.一名转移性黑色素瘤患者使用 pembrolizumab 后发生严重进行性瘢痕性蕈样肉芽肿。
Australas J Dermatol. 2021 Aug;62(3):403-406. doi: 10.1111/ajd.13660. Epub 2021 Jul 3.
3
Extensive lichen planopilaris as exclusive lichenoid reaction secondary to pembrolizumab in a patient with metastatic melanoma.一名转移性黑色素瘤患者中，广泛的扁平苔藓样毛发角化病作为帕博利珠单抗继发的唯一苔藓样反应。
Dermatol Ther. 2022 May;35(5):e15388. doi: 10.1111/dth.15388. Epub 2022 Feb 24.
4
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With Pembrolizumab.18F-FDG PET/CT 显示帕博利珠单抗治疗伊匹单抗难治性晚期黑色素瘤患者疾病缓解。
Clin Nucl Med. 2016 Feb;41(2):156-8. doi: 10.1097/RLU.0000000000001039.
5
Steroid-Refractory Lichenoid Eruption Associated with Pembrolizumab in a Patient with Non-Small Cell Lung Cancer.一名非小细胞肺癌患者中与帕博利珠单抗相关的类固醇难治性苔藓样皮疹
HCA Healthc J Med. 2021 Dec 29;2(6):397-400. doi: 10.36518/2689-0216.1198. eCollection 2021.
6
Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.抗程序性死亡受体 1 免疫治疗继发胰腺炎：FDG PET/CT 诊断。
Clin Nucl Med. 2015 Nov;40(11):e528-9. doi: 10.1097/RLU.0000000000000940.
7
Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma.一名接受派姆单抗治疗转移性黑色素瘤的患者发生播散性芽生菌病。
JAAD Case Rep. 2019 Jun 26;5(7):580-581. doi: 10.1016/j.jdcr.2019.05.001. eCollection 2019 Jul.
8
FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis.帕博利珠单抗相关性多器官肉样瘤病的 FDG PET/CT 病程。
Clin Nucl Med. 2019 Feb;44(2):167-168. doi: 10.1097/RLU.0000000000002408.
9
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.对抗PD-1治疗反应持久的转移性黑色素瘤患者的残留FDG-PET代谢活性
Pigment Cell Melanoma Res. 2016 Sep;29(5):572-7. doi: 10.1111/pcmr.12503. Epub 2016 Aug 4.
10
Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.使用氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描（FDG PET-CT）进行伊匹单抗免疫治疗黑色素瘤时的免疫介导疾病
Acad Radiol. 2017 Jan;24(1):111-115. doi: 10.1016/j.acra.2016.08.005. Epub 2016 Nov 4.

引用本文的文献

1
Scarring alopecia as an unexpected consequence of immune checkpoint inhibition.瘢痕性脱发作为免疫检查点抑制的意外后果。
JAAD Case Rep. 2025 May 8;61:1-6. doi: 10.1016/j.jdcr.2025.04.007. eCollection 2025 Jul.
2
Nivolumab-Induced Lichen Planopilaris: Case Report and Literature Review of Hair Disorders Associated with Targeted Oncological Therapies.纳武单抗诱发的扁平苔藓样毛发扁平苔藓：病例报告及与靶向肿瘤治疗相关的毛发疾病文献综述
Int J Trichology. 2023 May-Jun;15(3):105-107. doi: 10.4103/ijt.ijt_95_21. Epub 2023 Dec 1.
3
Steroid-Refractory Lichenoid Eruption Associated with Pembrolizumab in a Patient with Non-Small Cell Lung Cancer.

本文引用的文献

1
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.帕博利珠单抗诱导的大疱性类天疱疮样扁平苔藓发生于一名转移性黑色素瘤患者。
J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272. Epub 2017 Jun 16.
2
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.抗PD-1/PD-L1免疫检查点抗体的皮肤并发症
Curr Opin Oncol. 2016 Jul;28(4):254-63. doi: 10.1097/CCO.0000000000000290.
3
Pembrolizumab: A Review in Advanced Melanoma.帕博利珠单抗：晚期黑色素瘤综述
一名非小细胞肺癌患者中与帕博利珠单抗相关的类固醇难治性苔藓样皮疹
HCA Healthc J Med. 2021 Dec 29;2(6):397-400. doi: 10.36518/2689-0216.1198. eCollection 2021.
4
Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases.免疫检查点阻断治疗下的瘢痕性脱发：三例报告
Acta Derm Venereol. 2022 Oct 11;102:adv00792. doi: 10.2340/actadv.v102.2311.
5
Immunotherapy and Antivascular Targeted Therapy in Patients' Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge.器官移植后并发恶性肿瘤患者的免疫治疗和抗血管靶向治疗：机遇还是挑战。
J Immunol Res. 2022 Jun 2;2022:6440419. doi: 10.1155/2022/6440419. eCollection 2022.
6
Pembrolizumab-Induced Lichen Planus on the Scalp of a Patient with Non-Small-Cell Lung Carcinoma.帕博利珠单抗诱导的非小细胞肺癌患者头皮扁平苔藓
Case Rep Dermatol. 2021 Oct 8;13(3):487-491. doi: 10.1159/000519486. eCollection 2021 Sep-Dec.
Drugs. 2016 Mar;76(3):375-86. doi: 10.1007/s40265-016-0543-x.
4
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.帕博利珠单抗的皮肤不良事件及其与疾病进展的关联。
JAMA Dermatol. 2015 Nov;151(11):1206-1212. doi: 10.1001/jamadermatol.2015.1916.
5
The PD-1 pathway in tolerance and autoimmunity.PD-1 通路在耐受和自身免疫中的作用。
Immunol Rev. 2010 Jul;236:219-42. doi: 10.1111/j.1600-065X.2010.00923.x.